GU CANCERS SYMPOSIUM 2024 ROUNDTABLE DISCUSSION: Ambassador

GU CANCERS SYMPOSIUM 2024 ROUNDTABLE DISCUSSION: Ambassador

GU Cancers Symposium 2024 Roundtable
Icon Chair Speaker

Chair

Dr. Nazanin Fallah-Rad

Icon Chair Speaker

Panelists

Dr. Sebastien Hotte
Dr. Maria Jiang

This program has been made possible through unrestricted support from EMD Serono & Ipsen

Studies/trials discussed:

  • Ambassador Study
  • AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation.
  • AMBASSADOR: Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma
  • Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
  • Use of Adjuvant Nivolumab in Patients With Muscle-Invasive Urothelial Carcinoma: CheckMate 274
Tagged